Inspire Medical's Recovery from Temporary Q3 Revenue Shortfall - Analysts Find Optimism

Grand News Network | November 8, 2023

Tuesday, Inspire Medical Systems Inc (NYSE: INSP) released Q3 earnings, with sales of $153.3 million, up 40% Y/Y, beating the consensus of $154.45 million.

During the quarter, it activated 62 new centers in the U.S. in the third quarter of 2023, bringing the total to 1,107 U.S. medical centers providing Inspire therapy.

Guidance: Inspire increased and narrowed its FY23 revenue guidance to $608 million-$612 million compared to the prior revenue guidance of $600 million-$610 million and the consensus of $609.81 million.

The company also maintained its guidance relating to the opening of new U.S. medical centers of 52-56 per quarter for the remaining quarter of the year ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner